Suivre
Prakash Sundaramurthi
Prakash Sundaramurthi
Executive Director, Marinus Pharmaceutical Inc.,
Adresse e-mail validée de marinuspharma.com
Titre
Citée par
Citée par
Année
Trehalose crystallization during freeze-drying: implications on lyoprotection
P Sundaramurthi, R Suryanarayanan
The Journal of Physical Chemistry Letters 1 (2), 510-514, 2010
1022010
Solid-state characterization of mefenamic acid
R Panchagnula, P Sundaramurthy, O Pillai, S Agrawal, YA Raj
Journal of pharmaceutical sciences 93 (4), 1019-1029, 2004
842004
“pH Swing” In Frozen Solutions Consequence of Sequential Crystallization of Buffer Components
P Sundaramurthi, E Shalaev, R Suryanarayanan
The Journal of Physical Chemistry Letters 1 (1), 265-268, 2010
732010
Crystallization of trehalose in frozen solutions and its phase behavior during drying
P Sundaramurthi, TW Patapoff, R Suryanarayanan
Pharmaceutical research 27, 2374-2383, 2010
722010
Glycine crystallization in frozen and freeze-dried systems: effect of pH and buffer concentration
DB Varshney, S Kumar, EY Shalaev, P Sundaramurthi, SW Kang, ...
Pharmaceutical research 24, 593-604, 2007
652007
Influence of crystallizing and non-crystallizing cosolutes on trehalose crystallization during freeze-drying
P Sundaramurthi, R Suryanarayanan
Pharmaceutical research 27, 2384-2393, 2010
592010
Calorimetric and diffractometric evidence for the sequential crystallization of buffer components and the consequential pH swing in frozen solutions
P Sundaramurthi, E Shalaev, R Suryanarayanan
The Journal of Physical Chemistry B 114 (14), 4915-4923, 2010
522010
The effect of crystallizing and non-crystallizing cosolutes on succinate buffer crystallization and the consequent pH shift in frozen solutions
P Sundaramurthi, R Suryanarayanan
Pharmaceutical research 28, 374-385, 2011
412011
Calorimetry and complementary techniques to characterize frozen and freeze-dried systems
P Sundaramurthi, R Suryanarayanan
Advanced drug delivery reviews 64 (5), 384-395, 2012
402012
Phase transitions in frozen systems and during freeze–drying: quantification using synchrotron X-Ray diffractometry
DB Varshney, P Sundaramurthi, S Kumar, EY Shalaev, SW Kang, ...
Pharmaceutical research 26, 1596-1606, 2009
272009
Bioavailability enhancement of poorly water soluble and weakly acidic new chemical entity with 2-hydroxy propyl-β-cyclodextrin: selection of meglumine, a polyhydroxy base, as a …
S Basavaraj, V Sihorkar, TR Shantha Kumar, P Sundaramurthi, ...
Pharmaceutical development and technology 11 (4), 443-451, 2006
262006
Thermophysical properties of carboxylic and amino acid buffers at subzero temperatures: relevance to frozen state stabilization
P Sundaramurthi, R Suryanarayanan
The Journal of Physical Chemistry B 115 (21), 7154-7164, 2011
242011
Azithromycin Hydrates—Implications of Processing‐Induced Phase Transformations
P Sundaramurthi, R Suryanarayanan
Journal of Pharmaceutical Sciences 103 (10), 3095-3106, 2014
192014
Predicting the crystallization propensity of carboxylic acid buffers in frozen systems—relevance to freeze-drying
P Sundaramurthi, R Suryanarayanan
Journal of pharmaceutical sciences 100 (4), 1288-1293, 2011
172011
Physicochemical stability of pembrolizumab admixture solution in normal saline intravenous infusion bag
P Sundaramurthi, S Chadwick, C Narasimhan
Journal of Oncology Pharmacy Practice 26 (3), 641-646, 2020
152020
Physical characterization of pentamidine isethionate during freeze-drying—relevance to development of stable lyophilized product
P Sundaramurthi, MR Burcusa, R Suryanarayanan
Journal of pharmaceutical sciences 101 (5), 1732-1743, 2012
132012
Solute crystallization in the frozen and freeze-dried systems: Inhibition of crystallization to enhance pharmaceutical stability
P Sundaramurthi
University of Minnesota, 2010
32010
Effective Inhibition of Buffer Component Crystallization in the Frozen Solution by Lyoprotectants
P Sundaramurthi, D Varshney, S Kumar, SW Kang, R Suryanarayanan
AAPS J 10, S2, 2008
22008
Medroxyprogesterone acetate injectable compositions and methods of use
P Sundaramurthi
US Patent 11,135,154, 2021
12021
Medroxyprogesterone acetate injectable compositions and methods of use
P Sundaramurthi
US Patent 11,911,500, 2024
2024
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20